Prognostic Significance of Alterations in IDH Enzyme Isoforms in Patients With AML Treated With High Dose Cytarabine and Idarubicin

BACKGROUND: IDH1 and IDH2 gene mutations are novel, recurring molecular aberrations among patients with normal karyotype acute myeloid leukemia (AML). METHODS: Among 358 patients with AML treated on 4 protocols using high dose ara-C plus idarubicin induction, pre-treatment samples were available for...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Ravandi, Farhad, Patel, Keyur, Luthra, Rajyalakshmi, Faderl, Stefan, Konopleva, Marina, Kadia, Tapan, Brandt, Mark, Pierce, Sherry, Kornblau, Steven, Andreeff, Michael, Wang, Xuemei, Garcia-Manero, Guillermo, Cortes, Jorge, Kantarjian, Hagop
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4060157/
https://ncbi.nlm.nih.gov/pubmed/22020636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26580
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares